{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:48:17Z","timestamp":1790243297897,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"FNRS and the Walloon Region in the context of the funding of the strategic axis FRFS-WELBIO","award":["F.R.S.-FNRS, MIS F.4512.20, 40009849"],"award-info":[{"award-number":["F.R.S.-FNRS, MIS F.4512.20, 40009849"]}]},{"name":"Apog\u00e9ee programme of the Canadian Federal Tri-Agency via its support to the Sentinelle Nord program of Universit\u00e9 Laval"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BJC Rep"],"DOI":"10.1038\/s44276-026-00208-y","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:24:05Z","timestamp":1772623445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Changes in levels of endocannabinoidome mediators in mice with cancer cachexia: links with steatosis and gut microbial dysbiosis"],"prefix":"10.1038","volume":"4","author":[{"given":"Alexandra L.","family":"Degraeve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Cutignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Piscitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Villano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane M.","family":"Thibaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure B.","family":"Bindels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"208_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ccell.2023.02.007","volume":"41","author":"BR Pryce","year":"2023","unstructured":"Pryce BR, Wang DJ, Zimmers TA, Ostrowski MC, Guttridge DC. Cancer cachexia: involvement of an expanding macroenvironment. Cancer Cell. 2023;41:581\u20134.","journal-title":"Cancer Cell"},{"key":"208_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41571-023-00734-5","volume":"20","author":"JM Argiles","year":"2023","unstructured":"Argiles JM, Lopez-Soriano FJ, Stemmler B, Busquets S. Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management. Nat Rev Clin Oncol. 2023;20:250\u201364.","journal-title":"Nat Rev Clin Oncol"},{"key":"208_CR3","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3945\/ajcn.2008.27273","volume":"89","author":"JR Lieffers","year":"2009","unstructured":"Lieffers JR, Mourtzakis M, Hall KD, McCargar LJ, Prado CM, Baracos VE. A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands. Am J Clin Nutr. 2009;89:1173\u20139.","journal-title":"Am J Clin Nutr"},{"key":"208_CR4","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/jcsm.12684","volume":"12","author":"SA P\u00f6tgens","year":"2021","unstructured":"P\u00f6tgens SA, Thibaut MM, Joudiou N, Sboarina M, Neyrinck AM, Cani PD, et al. Multi-compartment metabolomics and metagenomics reveal major hepatic and intestinal disturbances in cancer cachectic mice. J Cachexia Sarcopenia Muscle. 2021;12:456\u201375.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"208_CR5","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1152\/ajpregu.00028.2019","volume":"317","author":"JL Halle","year":"2019","unstructured":"Halle JL, Pena GS, Paez HG, Castro AJ, Rossiter HB, Visavadiya NP, et al. Tissue-specific dysregulation of mitochondrial respiratory capacity and coupling control in colon-26 tumor-induced cachexia. Am J Physiol Regul Integr Comp Physiol. 2019;317:R68\u2013R82.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"208_CR6","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1139\/apnm-2019-0407","volume":"45","author":"ME Rosa-Caldwell","year":"2020","unstructured":"Rosa-Caldwell ME, Brown JL, Lee DE, Wiggs MP, Perry RA Jr., Haynie WS, et al. Hepatic alterations during the development and progression of cancer cachexia. Appl Physiol Nutr Metab. 2020;45:500\u201312.","journal-title":"Appl Physiol Nutr Metab"},{"key":"208_CR7","doi-asserted-by":"publisher","first-page":"18224","DOI":"10.18632\/oncotarget.24804","volume":"9","author":"LB Bindels","year":"2018","unstructured":"Bindels LB, Neyrinck AM, Loumaye A, Catry E, Walgrave H, Cherbuy C, et al. Increased gut permeability in cancer cachexia: mechanisms and clinical relevance. Oncotarget. 2018;9:18224\u201338.","journal-title":"Oncotarget"},{"key":"208_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2449586","volume":"17","author":"MM Thibaut","year":"2025","unstructured":"Thibaut MM, Roumain M, Piron E, Gillard J, Loriot A, Neyrinck AM, et al. The microbiota-derived bile acid taurodeoxycholic acid improves hepatic cholesterol levels in mice with cancer cachexia. Gut Microbes. 2025;17:2449586.","journal-title":"Gut Microbes"},{"key":"208_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0016-5085(03)00881-3","volume":"125","author":"A Ligresti","year":"2003","unstructured":"Ligresti A, Bisogno T, Matias I, De Petrocellis L, Cascio MG, Cosenza V, et al. Possible endocannabinoid control of colorectal cancer growth. Gastroenterology. 2003;125:677\u201387.","journal-title":"Gastroenterology"},{"key":"208_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.clnesp.2023.02.020","volume":"55","author":"K Ota","year":"2023","unstructured":"Ota K, Ota T, Nitta SI, Ueda T, Yamashita T, Ozawa T. The association of circulating endocannabinoids with cancer cachexia: a cross-sectional study. Clin Nutr ESPEN. 2023;55:20\u20139.","journal-title":"Clin Nutr ESPEN"},{"key":"208_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167179","volume":"1870","author":"S Dalle","year":"2024","unstructured":"Dalle S, Hiroux C, Koppo K. Endocannabinoid remodeling in murine cachexic muscle associates with catabolic and metabolic regulation. Biochim Biophys Acta Mol Basis Dis. 2024;1870:167179.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"208_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.molmet.2018.06.002","volume":"14","author":"F Fanelli","year":"2018","unstructured":"Fanelli F, Mezzullo M, Repaci A, Belluomo I, Ibarra Gasparini D, Di Dalmazi G, et al. Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism. Mol Metab. 2018;14:82\u201394.","journal-title":"Mol Metab"},{"key":"208_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/oby.21687","volume":"25","author":"S Zelber-Sagi","year":"2017","unstructured":"Zelber-Sagi S, Azar S, Nemirovski A, Webb M, Halpern Z, Shibolet O, et al. Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease. Obesity (Silver Spring). 2017;25:94\u2013101.","journal-title":"Obesity (Silver Spring)"},{"key":"208_CR14","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1172\/JCI200523057","volume":"115","author":"D Osei-Hyiaman","year":"2005","unstructured":"Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, Batkai S, et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest. 2005;115:1298\u2013305.","journal-title":"J Clin Invest"},{"key":"208_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cmet.2007.12.007","volume":"7","author":"WI Jeong","year":"2008","unstructured":"Jeong WI, Osei-Hyiaman D, Park O, Liu J, Batkai S, Mukhopadhyay P, et al. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab. 2008;7:227\u201335.","journal-title":"Cell Metab"},{"key":"208_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1476-5381.2009.00183.x","volume":"158","author":"AA Izzo","year":"2009","unstructured":"Izzo AA, Piscitelli F, Capasso R, Aviello G, Romano B, Borrelli F, et al. Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. Br J Pharmacol. 2009;158:451\u201361.","journal-title":"Br J Pharmacol"},{"key":"208_CR17","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1016\/j.mce.2008.01.026","volume":"286","author":"I Matias","year":"2008","unstructured":"Matias I, Petrosino S, Racioppi A, Capasso R, Izzo AA, Di Marzo V. Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: effect of high fat diets. Mol Cell Endocrinol. 2008;286:S66\u201378.","journal-title":"Mol Cell Endocrinol"},{"key":"208_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrendo.2015.211","volume":"12","author":"PD Cani","year":"2016","unstructured":"Cani PD, Plovier H, Van Hul M, Geurts L, Delzenne NM, Druart C, et al. Endocannabinoids-at the crossroads between the gut microbiota and host metabolism. Nat Rev Endocrinol. 2016;12:133\u201343.","journal-title":"Nat Rev Endocrinol"},{"key":"208_CR19","doi-asserted-by":"crossref","unstructured":"Suriano F, Manca C, Flamand N, Van Hul M, Delzenne NM, Silvestri C, et al. A lipidomics- and transcriptomics-based analysis of the intestine of genetically obese (ob\/ob) and diabetic (db\/db) mice: links with inflammation and gut microbiota. Cells. 2023;12:411.","DOI":"10.3390\/cells12030411"},{"key":"208_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15154-6","volume":"7","author":"P Mehrpouya-Bahrami","year":"2017","unstructured":"Mehrpouya-Bahrami P, Chitrala KN, Ganewatta MS, Tang C, Murphy EA, Enos RT, et al. Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity. Sci Rep. 2017;7:15645.","journal-title":"Sci Rep"},{"key":"208_CR21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.bbalip.2011.07.008","volume":"1811","author":"KC Verhoeckx","year":"2011","unstructured":"Verhoeckx KC, Voortman T, Balvers MG, Hendriks HF, Wortelboer MH, Witkamp RF. Presence, formation and putative biological activities of N-acyl serotonins, a novel class of fatty-acid derived mediators, in the intestinal tract. Biochim Biophys Acta. 2011;1811:578\u201386.","journal-title":"Biochim Biophys Acta"},{"key":"208_CR22","doi-asserted-by":"publisher","first-page":"9007","DOI":"10.1021\/bi0608008","volume":"45","author":"A Saghatelian","year":"2006","unstructured":"Saghatelian A, McKinney MK, Bandell M, Patapoutian A, Cravatt BF. A FAAH-regulated class of N-acyl taurines that activates TRP ion channels. Biochemistry. 2006;45:9007\u201315.","journal-title":"Biochemistry"},{"key":"208_CR23","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrd.2018.115","volume":"17","author":"V Di Marzo","year":"2018","unstructured":"Di Marzo V. New approaches and challenges to targeting the endocannabinoid system. Nat Rev Drug Discov. 2018;17:623\u201339.","journal-title":"Nat Rev Drug Discov"},{"key":"208_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2023.115252","volume":"226","author":"G Falascina","year":"2023","unstructured":"Falascina G, Bindels LB, Di Marzo V, Cutignano A. Validation of a fast and sensitive UPLC-MS\/MS quantitative method for N-acyl taurine analysis in biological samples. J Pharm Biomed Anal. 2023;226:115252.","journal-title":"J Pharm Biomed Anal"},{"key":"208_CR25","doi-asserted-by":"crossref","unstructured":"Potgens SA, Havelange V, Lecop S, Li F, Neyrinck AM, Bindels F, et al. Gut microbiome alterations at acute myeloid leukemia diagnosis are associated with muscle weakness and anorexia. Haematologica. 2024;109:3194\u2013208.","DOI":"10.3324\/haematol.2023.284138"},{"key":"208_CR26","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1096\/fj.201601346R","volume":"31","author":"MA Karwad","year":"2017","unstructured":"Karwad MA, Couch DG, Theophilidou E, Sarmad S, Barrett DA, Larvin M, et al. The role of CB(1) in intestinal permeability and inflammation. FASEB J. 2017;31:3267\u201377.","journal-title":"FASEB J"},{"key":"208_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/35102582","volume":"414","author":"F Rodriguez de Fonseca","year":"2001","unstructured":"Rodriguez de Fonseca F, Navarro M, Gomez R, Escuredo L, Nava F, Fu J, et al. An anorexic lipid mediator regulated by feeding. Nature. 2001;414:209\u201312.","journal-title":"Nature"},{"key":"208_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/1440-1681.13238","volume":"47","author":"H Tutunchi","year":"2020","unstructured":"Tutunchi H, Saghafi-Asl M, Ostadrahimi A. A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-alpha, on the management and prevention of obesity. Clin Exp Pharmacol Physiol. 2020;47:543\u201352.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"208_CR29","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.bbalip.2010.06.006","volume":"1801","author":"MG Balvers","year":"2010","unstructured":"Balvers MG, Verhoeckx KC, Plastina P, Wortelboer HM, Meijerink J, Witkamp RF. Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties. Biochim Biophys Acta. 2010;1801:1107\u201314.","journal-title":"Biochim Biophys Acta"},{"key":"208_CR30","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1016\/j.bbalip.2016.09.012","volume":"1861","author":"M Poland","year":"2016","unstructured":"Poland M, Ten Klooster JP, Wang Z, Pieters R, Boekschoten M, Witkamp R, et al. Docosahexaenoyl serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23-IL-17 signaling in macrophages. Biochim Biophys Acta. 2016;1861:2020\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"208_CR31","doi-asserted-by":"publisher","first-page":"24770","DOI":"10.1073\/pnas.1916288116","volume":"116","author":"TJ Grevengoed","year":"2019","unstructured":"Grevengoed TJ, Trammell SAJ, McKinney MK, Petersen N, Cardone RL, Svenningsen JS, et al. N-acyl taurines are endogenous lipid messengers that improve glucose homeostasis. Proc Natl Acad Sci USA. 2019;116:24770\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"208_CR32","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/ismej.2015.209","volume":"10","author":"LB Bindels","year":"2016","unstructured":"Bindels LB, Neyrinck AM, Claus SP, Le Roy CI, Grangette C, Pot B, et al. Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia. ISME J. 2016;10:1456\u201370.","journal-title":"ISME J"},{"key":"208_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","volume":"16","author":"L Cristino","year":"2020","unstructured":"Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol. 2020;16:9\u201329.","journal-title":"Nat Rev Neurol"},{"key":"208_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/jcsm.12652","volume":"12","author":"MM Thibaut","year":"2021","unstructured":"Thibaut MM, Sboarina M, Roumain M, P\u00f6tgens SA, Neyrinck AM, Destr\u00e9e F, et al. Inflammation-induced cholestasis in cancer cachexia. J Cachexia Sarcopenia Muscle. 2021;12:70\u201390.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"208_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1096\/fj.201500132","volume":"31","author":"MA Karwad","year":"2017","unstructured":"Karwad MA, Macpherson T, Wang B, Theophilidou E, Sarmad S, Barrett DA, et al. Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARalpha. FASEB J. 2017;31:469\u201381.","journal-title":"FASEB J"},{"key":"208_CR36","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.bbalip.2017.05.008","volume":"1862","author":"Y Wang","year":"2017","unstructured":"Wang Y, Balvers MGJ, Hendriks HFJ, Wilpshaar T, van Heek T, Witkamp RF, et al. Docosahexaenoyl serotonin emerges as most potent inhibitor of IL-17 and CCL-20 released by blood mononuclear cells from a series of N-acyl serotonins identified in human intestinal tissue. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862:823\u201331.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"208_CR37","doi-asserted-by":"crossref","unstructured":"Grevengoed TJ, Trammell SA, Svenningsen JS, Makarov MV, Nielsen TS, Jacobsen JCB et al. An abundant biliary metabolite derived from dietary omega-3 polyunsaturated fatty acids regulates triglycerides. J Clin Investig. 2021;131:e143861.","DOI":"10.1172\/JCI143861"},{"key":"208_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1194\/jlr.RA119000424","volume":"61","author":"C Manca","year":"2020","unstructured":"Manca C, Boubertakh B, Leblanc N, Deschenes T, Lacroix S, Martin C, et al. Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling. J Lipid Res. 2020;61:70\u201385.","journal-title":"J Lipid Res"},{"key":"208_CR39","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/s42003-023-05295-y","volume":"6","author":"N Forte","year":"2023","unstructured":"Forte N, Roussel C, Marfella B, Lauritano A, Villano R, De Leonibus E, et al. Olive oil-derived endocannabinoid-like mediators inhibit palatable food-induced reward and obesity. Commun Biol. 2023;6:959.","journal-title":"Commun Biol"},{"key":"208_CR40","doi-asserted-by":"publisher","first-page":"6554","DOI":"10.1021\/jm070678q","volume":"50","author":"G Ortar","year":"2007","unstructured":"Ortar G, Cascio MG, De Petrocellis L, Morera E, Rossi F, Schiano-Moriello A, et al. New N-arachidonoylserotonin analogues with potential \u201cdual\u201d mechanism of action against pain. J Med Chem. 2007;50:6554\u201369.","journal-title":"J Med Chem"}],"container-title":["BJC Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00208-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00208-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00208-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:24:07Z","timestamp":1772623447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44276-026-00208-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["208"],"URL":"https:\/\/doi.org\/10.1038\/s44276-026-00208-y","relation":{},"ISSN":["2731-9377"],"issn-type":[{"value":"2731-9377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Alexandra L. Degraeve, Adele Cutignano, Fabiana Piscitelli, Rosaria Villano, Giulia De Simone, Roberta Verde, Morgane M. Thibaut, Laure B. Bindels, and Vincenzo Di Marzo declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"7"}}